Tenax Therapeutics Ownership | Who Owns Tenax Therapeutics?

Tenax Therapeutics Ownership Summary

Tenax Therapeutics is owned by 5.36% institutional investors, 0.31% insiders, and 94.34% retail investors. Ikarian capital is the largest institutional shareholder, holding 2.45% of TENX shares. TD Health Sciences - I is the top mutual fund, with 4.33% of its assets in Tenax Therapeutics shares.

TENX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Tenax Therapeutics	5.36%	0.31%	94.34%
Sector	Healthcare Stocks	231.98%	10.74%	-142.72%
Industry	Biotech Stocks	381.47%	10.55%	-292.02%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Ikarian capital	967.60K	2.45%	$7.36M
Morgan stanley	596.38K	1.50%	$7.27M
Vr adviser	437.71K	1.11%	$3.33M
Rtw investments, lp	378.35K	0.96%	$2.88M
Siren	352.44K	0.89%	$2.68M
Boothbay fund management	352.21K	0.89%	$2.68M
Bvf inc/il	339.55K	0.86%	$2.58M
Vanguard group	255.66K	0.64%	$3.12M
Vivo capital	208.33K	0.53%	$1.59M
Marshall wace, llp	177.21K	0.45%	$1.35M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Ikarian capital	967.60K	0.74%	$7.36M
Velan capital investment management lp	83.33K	0.60%	$634.16K
Vr adviser	437.71K	0.19%	$3.33M
Vivo capital	208.33K	0.13%	$1.59M
Siren	352.44K	0.10%	$2.68M
Bvf inc/il	339.55K	0.10%	$2.58M
Integral health asset management	167.00K	0.09%	$1.27M
Boothbay fund management	352.21K	0.04%	$2.68M
Adar1 capital management	53.43K	0.04%	$406.59K
Rtw investments, lp	378.35K	0.04%	$2.88M

Top Buyers

Holder	Shares	% Assets	Change
Ikarian capital	967.60K	0.74%	967.60K
Morgan stanley	596.38K	0.00%	418.05K
Siren	352.44K	0.10%	352.44K
Boothbay fund management	352.21K	0.04%	352.21K
Vr adviser	437.71K	0.19%	339.14K

Top Sellers

Holder	Shares	% Assets	Change
Adar1 capital management	53.43K	0.04%	-102.13K
Dimensional fund advisors lp	-	-	-15.93K
Drw securities	-	-	-10.51K
Raymond james financial	-	-	-1.50K
Tower research capital llc (trc)	501.00	0.00%	-748.00

New Positions

Holder	Shares	% Assets	Change	Value
Ikarian capital	967.60K	0.74%	967.60K	$7.36M
Siren	352.44K	0.10%	352.44K	$2.68M
Boothbay fund management	352.21K	0.04%	352.21K	$2.68M
Marshall wace, llp	177.21K	0.00%	177.21K	$1.35M
Woodline partners lp	88.21K	0.00%	88.21K	$671.29K

Sold Out

Holder	Change
Wealthspire advisors	-1.00
Sbi securities	-2.00
Raymond james financial	-1.50K
Drw securities	-10.51K
Dimensional fund advisors lp	-15.93K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	19	-44.12%	2,128,813	-54.91%	5	3.76%	14	-30.00%	-	-100.00%
Sep 30, 2025	33	32.00%	4,720,737	111.51%	11	37.50%	20	150.00%	2	-50.00%
Jun 30, 2025	25	8.70%	2,231,961	11.24%	5	18.75%	8	-11.11%	4	33.33%
Mar 31, 2025	23	9.52%	2,006,422	47.29%	5	6.89%	9	-	3	-
Dec 31, 2024	21	10.53%	1,362,190	10.84%	8	26.45%	9	-43.75%	3	200.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
TD Health Sciences - I	270.61K	4.33%	-
Vanguard Total Stock Mkt Idx Inv	194.16K	3.11%	50.50K
Fidelity Advisor Biotechnology I	141.10K	2.26%	141.10K
Vanguard Institutional Extnd Mkt Idx Tr	70.20K	1.12%	-
Bridgeway Ultra-Small Company	44.90K	0.72%	44.90K
T. Rowe Price Health Sciences	21.18K	0.62%	-89.13K
Fidelity Extended Market Index	28.83K	0.46%	11.18K
DFA US Targeted Value I	13.39K	0.29%	-
Blackrock Extended Mkt Fund CF	16.41K	0.26%	16.41K
Extended Equity Market Fund K	14.08K	0.23%	14.08K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 08, 2025	Rich Stuart	Chief Medical Officer	Buy	$25.25K
Dec 09, 2025	Rich Stuart	Chief Medical Officer	Buy	$25.54K
Dec 03, 2025	Rich Stuart	Chief Medical Officer	Buy	$13.62K
Dec 04, 2025	Rich Stuart	Chief Medical Officer	Buy	$23.00K
Dec 02, 2025	Rich Stuart	Chief Medical Officer	Buy	$9.01K

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	13	-
2025 Q3	-	-
2025 Q2	-	-
2025 Q1	-	-
2024 Q4	-	-

TENX Ownership FAQ

Who Owns Tenax Therapeutics?

Tenax Therapeutics shareholders are primarily institutional investors at 5.36%, followed by 0.31% insiders and 94.33% retail investors. The average institutional ownership in Tenax Therapeutics's industry, Biotech Stocks , is 381.47%, which Tenax Therapeutics falls below.

Who owns the most shares of Tenax Therapeutics?

Tenax Therapeutics’s largest shareholders are Ikarian capital (967.6K shares, 2.45%), Morgan stanley (596.38K shares, 1.50%), and Vr adviser (437.71K shares, 1.11%). Together, they hold 5.05% of Tenax Therapeutics’s total shares outstanding.

Does Blackrock own Tenax Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Tenax Therapeutics.

Who is Tenax Therapeutics’s biggest shareholder by percentage of total assets invested?

Ikarian capital is Tenax Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.74% of its assets in 967.6K Tenax Therapeutics shares, valued at 7.36M$.

Who is the top mutual fund holder of Tenax Therapeutics shares?

TD Health Sciences - I is the top mutual fund holder of Tenax Therapeutics shares, with 4.33% of its total shares outstanding invested in 270.61K Tenax Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools